As of 2025-05-22, the Relative Valuation of Cytokinetics Inc (CYTK) is (140.37) USD. This relative valuation is based on P/E multiples. With the latest stock price at 32.66 USD, the upside of Cytokinetics Inc based on Relative Valuation is -529.8%.
The range of the Relative Valuation is (122.93) - (140.47) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.9x - 27.2x | 24.9x |
| Forward P/E multiples | 23.8x - 37.9x | 29.5x |
| Fair Price | (122.93) - (140.47) | (140.37) |
| Upside | -476.4% - -530.1% | -529.8% |
| Date | P/E |
| 2025-05-16 | -6.01 |
| 2025-05-15 | -5.78 |
| 2025-05-14 | -5.81 |
| 2025-05-13 | -5.93 |
| 2025-05-12 | -6.23 |
| 2025-05-09 | -6.14 |
| 2025-05-08 | -6.29 |
| 2025-05-07 | -6.40 |
| 2025-05-06 | -6.58 |
| 2025-05-05 | -7.11 |
| 2025-05-02 | -7.24 |
| 2025-05-01 | -8.32 |
| 2025-04-30 | -8.30 |
| 2025-04-29 | -8.00 |
| 2025-04-28 | -7.99 |
| 2025-04-25 | -7.83 |
| 2025-04-24 | -7.81 |
| 2025-04-23 | -7.36 |
| 2025-04-22 | -7.33 |
| 2025-04-21 | -7.35 |
| 2025-04-17 | -7.65 |
| 2025-04-16 | -7.59 |
| 2025-04-15 | -7.47 |
| 2025-04-14 | -7.71 |
| 2025-04-11 | -7.49 |
| 2025-04-10 | -7.33 |
| 2025-04-09 | -7.23 |
| 2025-04-08 | -6.70 |
| 2025-04-07 | -6.97 |
| 2025-04-04 | -7.24 |
| 2025-04-03 | -7.85 |
| 2025-04-02 | -7.80 |
| 2025-04-01 | -7.27 |
| 2025-03-31 | -7.79 |
| 2025-03-28 | -8.37 |
| 2025-03-27 | -8.33 |
| 2025-03-26 | -8.45 |
| 2025-03-25 | -8.63 |
| 2025-03-24 | -9.02 |
| 2025-03-21 | -8.80 |
| 2025-03-20 | -8.35 |
| 2025-03-19 | -8.42 |
| 2025-03-18 | -8.39 |
| 2025-03-17 | -8.70 |
| 2025-03-14 | -8.60 |
| 2025-03-13 | -8.60 |
| 2025-03-12 | -8.52 |
| 2025-03-11 | -8.60 |
| 2025-03-10 | -8.39 |
| 2025-03-07 | -8.42 |